Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients (CADIRIS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2012 by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
University of Witwatersrand, South Africa
Case Western Reserve University
The Wistar Institute
University of Pennsylvania
Information provided by (Responsible Party):
Juan G. Sierra Madero, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
ClinicalTrials.gov Identifier:
NCT00988780
First received: October 1, 2009
Last updated: November 22, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2013
  Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)